Effectiveness of Ginkgo biloba in treatment of subjective tinnitus

Comparing effectiveness of Ginkgo biloba with cinnarizine in tinnitus intencivity of patients with subjective tinnitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013011212101N1

Enrollment

Registered

2014-10-19

Start date

2012-03-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus. Tinnitus

Interventions

Intervention 1: Cinnarizine groups: Oral Cinnarizine 75 mg daily in three divided doses for 2 months of treatment. Intervention 2: Ginkgo biloba: Oral Ginkgo biloba 120-140 mg daily in 2to 3 divided

Treatment - Drugs

Cinnarizine groups: Oral Cinnarizine 75 mg daily in three divided doses for 2 months of treatment

Ginkgo biloba: Oral Ginkgo biloba 120-140 mg daily in 2to 3 divided doses for 2 months of treatment

Eligibility

Sex/Gender

All

Age

26 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with tinnitus for over 18 years; patients less than 70 years who had definite pathological examination Exclusion criteria: previous use of drugs Ginkgo biloba, anti-coagulant drug use; history of hypertension; pregnant or planning to get pregnant; to be any unexpected complications, patient dissatisfaction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Subjective tinnitus. Timepoint: 2 months. Method of measurement: Audiometry.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026